Comparative effectiveness of ticagrelor, prasugrel, and clopidogrel for secondary prophylaxis in acute coronary syndrome

被引：0
|
作者：
Farley, Joel F. [1 ]
Kumar, Arun [2 ]
Lutsey, Pamela [3 ]
St Peter, Wendy [4 ]
Schommer, Jon [4 ]
Van't Hof, Jeremy [5 ]
Rajpurohit, Abhijeet [4 ]
机构：
[1] Univ Minnesota, Coll Pharm, Minneapolis, MN USA
[2] Univ Cincinnati, Coll Pharm, Cincinnati, OH USA
[3] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA
[4] Univ Minnesota, Dept Pharmaceut Care & Hlth Syst, Coll Pharm, Minneapolis, MN 55455 USA
[5] Univ Minnesota, Med Sch, Cardiovasc Div, Minneapolis, MN 55455 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
329
引用
收藏
页码：143 / 144
页数：2
相关论文
共 50 条
  • [1] Comparative Effectiveness of Ticarelor, Prasugrel, and Clopidogrel for Secondary Prophylaxis in Acute Coronary Syndrome: A Propensity Score-Matched Cohort Study
    Kumar, Arun
    Lutsey, Pamela L.
    St Peter, Wendy L.
    Schommer, Jon C.
    Van't Hof, Jeremy R.
    Rajpurohit, Abhijeet
    Farley, Joel F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (02) : 401 - 411
  • [2] COMPARATIVE EFFECTIVENESS OF TICAGRELOR VS. PRASUGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Kim, K.
    Lee, T. A.
    Ardati, A. K.
    Didomenico, R. J.
    Touchette, D.
    Walton, S. M.
    VALUE IN HEALTH, 2015, 18 (07) : A376 - A376
  • [3] Alternatives to clopidogrel for acute coronary syndromes: Prasugrel or ticagrelor?
    Biondi-Zoccai, Giuseppe
    Lotrionte, Marzia
    Gaita, Fiorenzo
    WORLD JOURNAL OF CARDIOLOGY, 2010, 2 (06): : 131 - 134
  • [4] Clopidogrel, prasugrel, or ticagrelor use and clinical outcome in patients with acute coronary syndrome
    Rezaei, S.
    Geroldinger, A.
    Heinze, G.
    Reinhardt, B.
    Wolzt, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S392 - S392
  • [5] A Reconciliation Attempt of the Acute Coronary Syndrome Clinical Trials on Clopidogrel, Prasugrel, and Ticagrelor
    Rietdijk, Wim J. R.
    Mandigers, Loes
    den Uil, Corstiaan A.
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (03) : 439 - 441
  • [6] A Reconciliation Attempt of the Acute Coronary Syndrome Clinical Trials on Clopidogrel, Prasugrel, and Ticagrelor
    Wim J. R. Rietdijk
    Loes Mandigers
    Corstiaan A. den Uil
    Cardiovascular Drugs and Therapy, 2020, 34 : 439 - 441
  • [7] Comparative effectiveness of prasugrel versus ticagrelor for the prevention of cardiovascular diseases in patients with acute coronary syndrome
    Dawwas, Ghadeer
    Dietrich, Eric
    Winchester, David E.
    Winterstein, Almut G.
    Segal, Richard
    Park, Haesuk
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 364 - 364
  • [8] Ticagrelor or prasugrel for patients with acute coronary syndrome
    Vaux, J.
    ANNALES FRANCAISES DE MEDECINE D URGENCE, 2020, 10 (06): : 414 - 415
  • [9] Comparative Effectiveness and Safety of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome: A Retrospective Cohort Analysis
    Dawwas, Ghadeer K.
    Dietrich, Erich
    Winchester, David E.
    Winterstein, Almut G.
    Segal, Richard
    Park, Haesuk
    PHARMACOTHERAPY, 2019, 39 (09): : 912 - 920
  • [10] Effectiveness of switching 'low responders' to prasugrel to ticagrelor after acute coronary syndrome
    Bassez, Clemence
    Deharo, Pierre
    Pankert, Mathieu
    Bonnet, Guillaume
    Quilici, Jacques
    Lambert, Marc
    Verdier, Valentine
    Morange, Pierre
    Alessi, Marie-Christine
    Bonnet, Jean-Louis
    Cuisset, Thomas
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (03) : 1181 - 1182
12345